Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MO/Kansas City
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kansas City, MO

Studies commonly pay $75 to $4,500 per completed study

1,000 clinical trials are currently recruiting participants within 30 miles of Kansas City. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,000studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Kansas City right now

Top 25 of 1,000 recruiting studies, sorted by proximity — each links to its official registry page

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
University of Kansas Cancer Center — Westwood, Kansas (6.7 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Fibromyalgia Phase 3 Interventional 620 participants sought
Clinical Research Site — Overland Park, Kansas (11.6 mi) · Sponsor: Axsome Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07398417)

Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

HPV-unrelated Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 81 participants sought
Saint Luke's Hospital — Kansas City, Missouri (2.1 mi) · Sponsor: Washington University School of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT04966481)

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis Phase 2 Interventional 180 participants sought
University of Kansas Medical Center Research Institute Inc. — Kansas City, Kansas (4.0 mi) · Sponsor: ACADIA Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07029581)

Naltrexone Neuroimaging in Teens With Eating Disorders

Eating Disorders, Binge Eating EARLY/Phase 1 Interventional 60 participants sought
Children's Mercy Research Institute — Kansas City, Missouri (2.1 mi) · Sponsor: Children's Mercy Hospital Kansas City
See eligibility & contact on ClinicalTrials.gov (NCT05509257)

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy N/A Interventional 105 participants sought
University of Kansas Medical Center — Kansas City, Kansas (4.0 mi) · Sponsor: Medtronic Cardiac Rhythm and Heart Failure
See eligibility & contact on ClinicalTrials.gov (NCT05839730)

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Phase 1 Interventional 36 participants sought
University of Kansas Hospital — Kansas City, Kansas (4.0 mi) · Sponsor: PeproMene Bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05370430)

The Vanguard Study: Testing a New Way to Screen for Cancer

Bladder Carcinoma, Breast Carcinoma N/A Interventional 24,000 participants sought
Saint Luke's Hospital of Kansas City — Kansas City, Missouri (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06995898)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck Phase 1 Interventional 1,006 participants sought
The University of Kansas Hospital — Kansas City, Kansas (4.0 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04389632)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
University of Kansas Cancer Center at North Kansas City Hospital — North Kansas City, Missouri (0.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Amyloidosis, Amyloid Cardiomyopathy Phase 3 Interventional 587 participants sought
St. Luke's Hospital of Kansas City — Kansas City, Missouri (2.1 mi) · Sponsor: Eidos Therapeutics, a BridgeBio company
See eligibility & contact on ClinicalTrials.gov (NCT06563895)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — Kansas City, Kansas (4.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Sudan Virus Disease Phase 1 Interventional 112 participants sought
Johnson County Clin-Trials — Lenexa, Kansas (15.2 mi) · Sponsor: International AIDS Vaccine Initiative
See eligibility & contact on ClinicalTrials.gov (NCT07565090)

Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)

Acute Stress Reaction, Acute Stress Disorder Phase 2 Interventional 180 participants sought
University of Kansas Medical Center — Kansas City, Kansas (4.0 mi) · Sponsor: University of North Carolina, Chapel Hill
See eligibility & contact on ClinicalTrials.gov (NCT06636786)

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Polymyositis, Dermatomyositis Phase 3 Interventional 240 participants sought
Research Site — Fairway, Kansas (8.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06455449)

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

Androgen Axis Suppression, Prostatectomy Phase 3 Interventional 120 participants sought
University of Kansas Medical Center — Kansas City, Kansas (4.0 mi) · Sponsor: M.D. Anderson Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT06274047)

Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study

Autonomic Dysfunction, Orthostatic Intolerance N/A Observational 400 participants sought
Research Medical Center Clinic — Kansas City, Missouri (2.1 mi) · Sponsor: Kansas City Heart Rhythm Research Foundation
See eligibility & contact on ClinicalTrials.gov (NCT06289413)

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

Influenza Phase 1 Interventional 78 participants sought
Altasciences Inc - Kansas City — Overland Park, Kansas (11.6 mi) · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
See eligibility & contact on ClinicalTrials.gov (NCT07169318)

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Lung Cancer, NSCLC N/A Observational 25 participants sought
The University of Kansas Cancer Center, Westwood Campus — Kansas City, Kansas (4.0 mi) · Sponsor: Jun Zhang, MD, PhD
See eligibility & contact on ClinicalTrials.gov (NCT05332925)

RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age

Uveitis N/A Observational 290 participants sought
Children's Mercy Kansas City Division of Rheumatology, Division of Rheumatology — Kansas City, Kansas (4.0 mi) · Sponsor: Meyer Children's Hospital IRCCS
See eligibility & contact on ClinicalTrials.gov (NCT06273748)

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Asthma, COPD Phase 1 Interventional 260 participants sought
University of Kansas Medical Center — Kansas City, Kansas (4.0 mi) · Sponsor: Mario Castro, MD, MPH
See eligibility & contact on ClinicalTrials.gov (NCT04624490)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Children's Mercy Hospitals and Clinics — Kansas City, Missouri (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)
Google-rated

Top-rated research centers in Kansas City

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

KCU Dybedal Center

1750 Independence Ave, Kansas City, MO 64106
(800) 234-4847

Spectrum Clinical Research

★ 4.0
2700 Clay Edwards Dr #260, Kansas City, MO 64116
(816) 562-6466
"The staff are very friendly and professional. I was very pleased with service I received. I was treated with respect and they answered all of my ques…"
— Terri Carter, 4★

University of Kansas Medical Center Research Institute

★ 5.0
3901 Rainbow Blvd, Kansas City, KS 66160
(913) 588-1261
"The doctors are very nice and helpful."
— Everian Williams, 5★

Qieon Research Laboratories

★ 5.0
405 Southwest Blvd #137 Floor 13, Kansas City, MO 64108
(913) 230-9170
"We have been following this company for a very long time. They have technological abilities that are indistinguishable from magic"
— Project Project, 5★

KCU: Dybedal Center for Research

1750 Independence Ave, Kansas City, MO 64106
(816) 654-7000

Kansas City Research Institute

★ 5.0
6667 Holmes Rd Ste 129, Kansas City, MO 64131
(816) 759-5274
"Professional, quick & efficient"
— Michael Fleschman, 5★

Clinical Research Consultants

★ 4.6
3930 Washington St, Kansas City, MO 64111
(816) 756-1222
"They are the best especially my girl chandrika.she comes with great medical knowledge.i recommend everyone to Check them out."
— Edna Yancy, 5★

The University of Kansas Clinical Research Center

★ 4.8 (6 reviews)
4350 Shawnee Mission Pkwy, Fairway, KS 66205
(913) 588-1227
"Westwood Internal Medicine is staffed with healthcare professionals who are well trained. Their credentials are impressive and well served to the hig…"
— Rebecca Jones, 5★

Children's Mercy Research Institute

★ 5.0
2401 Gillham Rd, Kansas City, MO 64108
(816) 234-3000
"Hospital Kids Children's Mercy"
— Leyela Long, 5★

Clinical trials in Kansas City: what's recruiting

The Kansas City area currently has 1,000 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kansas City, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular3 studies
  • Liver & Kidney1 studies
  • Diabetes & Metabolism1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Kansas City, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kansas City

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kansas City participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Kansas City pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Kansas City?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Kansas City safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Kansas City?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Kansas City.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kansas City typically complete one or two studies per year.

Paid clinical trials near Kansas City

Other metros within reach

Kansas City, KS1,011 Overland Park, KS999 Olathe, KS1,006 Topeka, KS110 Columbia, MO264 Springfield, MO157 Omaha, NE597 Des Moines, IA226

More of MO

St. Louis1,481 Columbia264 Springfield157

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts